View
278
Download
0
Category
Preview:
Citation preview
21
-12-
27. Press-Through-Package (PTP)
PTP PTP phantom
CT
,
28. CT
IVR
29. 320 Area DetectorCT
: 320 ADCT
21 320 ADCT
4~6ml/ 6 7 15ml
(ZAIO
WORKSTISTION system1000) VR
VR
27 25 VR
10
21
-13-
320 ADCT
30. 2MP v/s 6MsP LCD
ISD technology 1 3
X
CT 8mm
100HU 10mm50HU 90 180
1693mAs 60 7
ROC Az 6MsP
0.8672MP 0.817 6MsP (t-test; p=0.0064)
3MP
31. Solitary Fibrous Tumor
SFT
SFT
63
8cm CT T1 T2
T2SFT
32.
21
-14-
CT
33. 1
14 2007 2008 12
MMG 87cm
US EDB
MRI
T1WI FST2WI
34. 1
60
CT
MRI T2
35.
21
-15-
61 1
15mm MRI
T1 T2
PET FDG
(SUV max2.5)
36.
IVR
37. Telangiectatic/Inflammatory Adenoma
Telangiectatic/Inflammatory Adenoma TA 21 60
CT MR TWI T2WI
EOB TA 2 30
CT
MR T1WI T2WI EOB TA
telangiectatic FNH TA
38. 3T-PACE-DWI
21
-16-
16 -
3 33 8 3
3
Mann-Whitney
1
39. EOB MRI
EOB MRI F
F 56 F0;3 F1;6 F2;4 F3;15 F4;28
Liver CEI
Liver SIHBP DWI = 500 s/mm2 ADCLiver ADC
F Liver CEILiver SIHBPLiver ADCAlbT-BilPT
Child-Pugh score F1 F4 53
F2F3F4 Liver CEILiver SIHBPLiver ADC Az
56 Liver CEI F= 0.61, P < .001
7.4 + (-1.5)Liver CEI(-0.03)PTR2 = 0.53Liver CEILiver
ADC F2F3F4 F1F2F3 Liver CEI
Az
EOB MRI Liver CEI F
40. Gd-EOB-DTPA MRI
Gd-EOB-DTPA MRI
25 32 20 292
EOB MRI
88%
79%3 28% 21%
91%
Gd-EOB-DTPA MRI
21
-17-
41. Bilio-vascular compression
1
CTSMVSMVPVcavernous
transformation
2 US MRI CA
follow
42. CT320-slice volume scan 64-slice helical scan
CT 320 Volume
Scan 64 Helical Scan
Volume Scan 320 48 Helical Scan 64 48
CT SDDLPMPRVR
320 64 DLP 42.3P
21
-18-
Foreign body granuloma
44. 1
60CT
MRI T1WI, T2WI
DWI
ERCP
45. Groove 1
66 CT
CTMRI
GIF
Groove GIST
SMV
Groove
46.
IVR
3 MRIT2WI
T1WI
21
-19-
CT 1. 2.
3.
SCTserous cystic
tumorMCTmucinous cystic tumor
CT
47.
6 2
X
7.55.5cm mesodivertucular band
CT
48. 1
15
acoustic shadow
CT
49.
21
-20-
68
4
13
5 3
50. CT colonography 2
1 60 4 Air image
MPR
CT colonography
CTC
2 404Air image
MPR
CTC
CTC
CTC
51.
26
21
-21-
12
52. IgG4 Sclerosingmesenteritis
70 CT
94mm
MRIT2
CT 131I-MIBG
18F-FGD-PET FDG
SUV 5.7 ESD
IgG4
53. epithelioidhemangioendothelioma
40
3cm CT
dynamic MRI T1WI T2WI
RCC AML with minimal fat
epithelioidhemangioendothelioma(EHE
)EHE intermediate
malignancy
54. neuromelanin paraganglioma
60 2
21
-22-
CT
MRI T1
T2 T1T2
neuromelanin paraganglioma
55.
60
2009 1 11
CT 68x85x135mm
MRI T1WI T2WI
FDG-PET (SUV max
1.5)
56.
40 30
TCF
CT cm
S
MRI T1 T2
CT
21
-23-
57. 2
150 4
US
220
58.
60
MRI 6cm
T1WI T2WI
+
1
59. IgE
40 2
CT S6
adenocarcinoma
21
-24-
Aspergillusfumigatus+D2
IgE
60. IgG4
68 IgG4 316mg/dl
CT
PET
IgG4
IgG4
IgG4CT
cT3N2M0
61.
IVR
50 CT S8
CT S8 2011mm
MRIT1WI
T2WI SFThyalinizinggranuloma
tuberculoma S8a
T2WI
62. CT
CT
2006 5
3cm 80
21
-25-
CT
CT
CT
63. glomus tumor
38 XCTMRI
37x24x29mmCT44HU166HU
127HU MRIT1 T2
glomus
tumor
paraganglioma
64. CT Perfusion SPECT
SPECT CT Perfusion(CTP)
5 CTP FWHM12mm gaussian
smoothing123I-IMP SPECT CTP
128128 NMI
SPECT CTP
CTP
65.
10 8 2009 10 A
21
-26-
1 PCR
MRI 1
MRI 1
-
2
66. ecchordosisphysaliphora
Ecchordosisphysaliphora 2
1 33
CTMRI
T2 T1
8261 MRI
3
EP
67. MALT
46 2005 10 10
CT
10 12 MRI T1WI , T2WI
Gd
11 15
MALT type B-cell Lymphoma
11 24(R-MEDOCH)
68. Intraosseousmeningioma
21
-27-
33CT
MRI T2
Intraosseousmeningioma
69.
80
10
PSA
70.
Horner
Recommended